Ahmad T Mansour1,2, Alaleh Esmaeili Shandiz1, Michelle K Zimmerman1, Trenton D Roth3, Jiehao Zhou1. 1. Department of Pathology and Laboratory Medicine, School of Medicine, Indiana UniversityIndianapolis, Indiana 46202, USA. 2. Department of Pathology, Microbiology, Forensic Medicine, School of Medicine, University of JordanAmman, Jordan. 3. Department of Radiology and Imaging Sciences, School of Medicine, Indiana UniversityIndianapolis, Indiana 46202, USA.
Abstract
BACKGROUND: Lymphoplasmacytic lymphoma and plasma cell myeloma are two B cell lymphoproliferative neoplasms derived from mature B-lymphocytes in different differentiation stages. The coexistence of these two tumors in the same patient is exceedingly rare and can be difficult to diagnose. CASE PRESENTATION: A 76-year-old male presented with a pathologic fracture after a fall. Radiography showed a lytic lesion in the pelvis. Serum immunofixation showed distinct IgM kappa and IgA kappa monoclonal protein bands. Bone marrow examination revealed aggregates of small, mature lymphoid cells with admixed plasma cells. Immunohistochemical studies and flow cytometric analysis showed the lymphoid cells were CD10-/CD5- kappa restricted monoclonal B cells. The plasma cells were monoclonal with kappa light chain restriction. The majority of plasma cells were positive for IgA and cyclin D1 with a few plasma cells positive for IgM. Additional studies showed the presence of both a positive MYD88 L265P mutation and a CCND1/IGH fusion. A diagnosis of concomitant lymphoplasmacytic lymphoma and plasma cell myeloma was rendered. CONCLUSION: Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma can be rarely encountered and is diagnostic challenging. It is commonly associated with biclonal monoclonal proteins. This case demonstrates the importance of a comprehensive work-up in the diagnosis of this disease combination and highlights the diagnostic role of MYD88 mutation study.
BACKGROUND:Lymphoplasmacytic lymphoma and plasma cell myeloma are two B cell lymphoproliferative neoplasms derived from mature B-lymphocytes in different differentiation stages. The coexistence of these two tumors in the same patient is exceedingly rare and can be difficult to diagnose. CASE PRESENTATION: A 76-year-old male presented with a pathologic fracture after a fall. Radiography showed a lytic lesion in the pelvis. Serum immunofixation showed distinct IgM kappa and IgA kappa monoclonal protein bands. Bone marrow examination revealed aggregates of small, mature lymphoid cells with admixed plasma cells. Immunohistochemical studies and flow cytometric analysis showed the lymphoid cells were CD10-/CD5- kappa restricted monoclonal B cells. The plasma cells were monoclonal with kappa light chain restriction. The majority of plasma cells were positive for IgA and cyclin D1 with a few plasma cells positive for IgM. Additional studies showed the presence of both a positive MYD88L265P mutation and a CCND1/IGH fusion. A diagnosis of concomitant lymphoplasmacytic lymphoma and plasma cell myeloma was rendered. CONCLUSION: Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma can be rarely encountered and is diagnostic challenging. It is commonly associated with biclonal monoclonal proteins. This case demonstrates the importance of a comprehensive work-up in the diagnosis of this disease combination and highlights the diagnostic role of MYD88 mutation study.
Authors: Steven P Treon; Lian Xu; Guang Yang; Yangsheng Zhou; Xia Liu; Yang Cao; Patricia Sheehy; Robert J Manning; Christopher J Patterson; Christina Tripsas; Luca Arcaini; Geraldine S Pinkus; Scott J Rodig; Aliyah R Sohani; Nancy Lee Harris; Jason M Laramie; Donald A Skifter; Stephen E Lincoln; Zachary R Hunter Journal: N Engl J Med Date: 2012-08-30 Impact factor: 91.245
Authors: Giovanni Carulli; Eugenio M Ciancia; Antonio Azzarà; Virginia Ottaviano; Susanna Grassi; Elena Ciabatti; Maria I Ferreri; Melania Rocco; Alessandra Marini; Mario Petrini Journal: J Clin Exp Hematop Date: 2013
Authors: Steven P Treon; Zachary R Hunter; Jorge J Castillo; Giampaolo Merlini Journal: Hematol Oncol Clin North Am Date: 2014-08-05 Impact factor: 3.722
Authors: Christina Hanzis; Rohit P Ojha; Zachary Hunter; Robert Manning; Megan Lewicki; Philip Brodsky; Leukothea Ioakimidis; Christina Tripsas; Christopher J Patterson; Patricia Sheehy; Steven P Treon Journal: Clin Lymphoma Myeloma Leuk Date: 2011-02
Authors: Charles Ronsin; Christine Kandel-Aznar; Yannick Le Bris; Clément Deltombe; Nicolas Blin; Simon Ville Journal: J Nephrol Date: 2021-09-08 Impact factor: 3.902